CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Marion LEBOYER

OPENALEX: A5043863759↗ORCID: 0000-0001-5473-3697↗

Affiliations

Organizations

Assistance Publique – Hôpitaux de Parisauthorship · FR Centre Hospitalier Charles Perrensauthorship · FR Centre Hospitalier Universitaire Henri-Mondorauthorship · FR Centre National de la Recherche Scientifiqueauthorship · FR Fondation FondaMentalauthorship · FR Hôpital Albert-Chenevierauthorship · FR Hôpitaux Universitaires Henri-Mondorauthorship · FR Insermauthorship · FR Institut de Neurosciences Cognitives et Intégratives d’Aquitaineauthorship · FR Institut Mondor de Recherche Biomédicaleauthorship · FR Université de Bordeauxauthorship · FR Université Paris-Est Créteilauthorship · FR

Public evidence

2 connected articles

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open Access The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.2019 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Marion LEBOYER - Medical Cannabis Research Engine